News & Analysis as of

Marijuana Related Businesses Coronavirus/COVID-19 Cannabis Products

Husch Blackwell LLP

BOLO: Cannabis Qui Tam Actions

Husch Blackwell LLP on

Due to federal illegality, the cannabis industry has long been plagued by federal agencies taking a variety of different enforcement approaches to cannabis businesses. From the U.S. Patent and Trademark Office to the National...more

Perkins Coie

Cannabis Legal Report - January 2023

Perkins Coie on

New York City Attempts to Crack Down on Illicit Cannabis Market - During a council hearing on Jan. 18, 2023, New York City lawmakers and law enforcement officials discussed the need for tackling the city’s illicit cannabis...more

Bradley Arant Boult Cummings LLP

COVID and CBD Prove to be a Powder Keg for Federal Regulators

Cannabis operators (from marijuana to hemp-derived products such as CBD) often get the sense they are one of the central targets of the federal government’s reach. But they are not in the same league lately as the COVID-19...more

Foley Hoag LLP

Commonwealth Ends State of Emergency

Foley Hoag LLP on

As of today – June 15, 2021 – the Commonwealth’s State of Emergency related to the COVID-19 pandemic has ended. Although the Cannabis Control Commission (“Commission”) has issued bulletins and administrative orders that...more

Bass, Berry & Sims PLC

FDA Increases Scrutiny of CBD Companies for Marketing and Labeling Practices

Bass, Berry & Sims PLC on

As the market for hemp-based products booms, many investors are grappling with (and consumers unaware of) the grey area within which hemp products­­ are being commercialized across the country. Increasing demand for...more

Farrell Fritz, P.C.

Taxing Cannabis During The Pandemic

Farrell Fritz, P.C. on

How Are You Doing? How are you coping with social distancing? Are you working remotely? If so, has it been as “seamless” as you would have others believe? Have you snuck out to visit family or close friends, or have they...more

Harris Beach PLLC

The State of Cannabis in New York

Harris Beach PLLC on

New York state seemed poised to legalize marijuana in 2020 – but those efforts, like so many others, were thwarted by COVID-19. However, we can expect this unfinished business to remain on the radar – with legalization seen...more

Seyfarth Shaw LLP

The Week in Weed: May 2020 #4

Seyfarth Shaw LLP on

The news getting the most attention this week is the reopening of Massachusetts’ recreational marijuana shops, scheduled for May 25. Senator Mitch McConnell (R-KY) criticized the cannabis banking provisions in the latest...more

Bennett Jones LLP

Health Canada Provides Update to Cannabis Licence Holders on Temporary COVID-19 Relief Measures

Bennett Jones LLP on

On April 30, 2020, Health Canada announced the extension of temporary relief measures, initially announced on March 24, 2020, for Canadian licence holders in connection with the COVID-19 pandemic, as well as some new...more

Seyfarth Shaw LLP

The Week in Weed: May 2020

Seyfarth Shaw LLP on

Our top story this week is a bill that would allow cannabis companies to receive federal stimulus money, and the support it has attracted. Ballot issues continue in Florida and Montana. The FDA is cracking down on CBD...more

Seyfarth Shaw LLP

The Week in Weed: April 2020 #4

Seyfarth Shaw LLP on

Yet again,COVID-19 dominated the news, in the marijuana industry and in every other aspect of life. The lack of funding for marijuana businesses in the stimulus packages, the halt to state legalization efforts, the issues...more

Husch Blackwell LLP

State-By-State COVID-19 Announcements Impacting Marijuana Businesses

Husch Blackwell LLP on

Disclaimer: Below is a state-wide analysis of the current legal environment for the cannabis industry in light of the recent COVID-19 pandemic. This analysis highlights the ability of both medical and retail marijuana...more

Burns & Levinson LLP

COVID-19 Stalls Pending Recreational Efforts but Spurs Long-Term Industry Optimism

Burns & Levinson LLP on

Cannabis legalization and program launches have been stalled as states have turned their focus to addressing the ongoing COVID-19 crisis. As was recently discussed on the CannaBusiness Advisory, the State of New York was...more

Tonkon Torp LLP

Top 6 Ways To Protect A Cannabis Business Brand

Tonkon Torp LLP on

As I previously discussed in my article and podcast published in the Portland Business Journal, U.S. federal trademark law does not currently extend to cannabis products. Because the required “use in commerce” of the cannabis...more

Cozen O'Connor

Controlled Substances, CBD and COVID-19

Cozen O'Connor on

While the country wrestles with the coronavirus pandemic, the federal government and many state governments recently made key determinations that could shape the future of the cannabis, hemp, and CBD industries for years to...more

Foley & Lardner LLP

Implications for the Cannabis Industry Due to the Coronavirus

Foley & Lardner LLP on

As the coronavirus pandemic grips the United States, many state and local governments have enacted stay in place restrictions that limit not only routine personal activity but commercial activities as well. In the absence of...more

Sheppard Mullin Richter & Hampton LLP

Nota Bene Episode 73: “Quarantine and Chill”: Will COVID-19 Impact the Cannabis Industry?

The uncertainty of the novel coronavirus (COVID-19) has permeated every aspect of our society - personally and economically. As we continue to navigate this “new normal,” we’re taking a closer look at how the virus might...more

Fox Rothschild LLP

Cannabis Companies Deemed ‘Essential’ Businesses In Some States, But Not All

Fox Rothschild LLP on

Like all businesses navigating the current COVID-19 crisis, cannabis companies are eager to understand how state and local orders will impact their operations. As states issue orders requiring all but essential businesses to...more

Sheppard Mullin Richter & Hampton LLP

Nota Bene Episode 71: Shifting Regulatory Landscapes at the FDA: Cannabis, Vaping and Intelligent Medical Devices with Allison...

2019 ushered in numerous changes and new initiatives at the U.S. Food and Drug Administration (FDA). From the increasing popularity of cannabis use to the rapidly evolving nature of artificial intelligence in medical devices,...more

19 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide